3D-QSAR-Assisted Design, Synthesis, and Evaluation of Novobiocin Analogues
- 29 November 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 4 (1), 57-62
- https://doi.org/10.1021/ml300275g
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- 3-Arylcoumarin Derivatives Manifest Anti-proliferative Activity through Hsp90 InhibitionACS Medicinal Chemistry Letters, 2012
- Engineering an Antibiotic to Fight Cancer: Optimization of the Novobiocin Scaffold to Produce Anti-proliferative AgentsJournal of Medicinal Chemistry, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Cytotoxic sugar analogues of an optimized novobiocin scaffoldMedChemComm, 2010
- Synthesis and Evaluation of Noviose Replacements on Novobiocin That Manifest Antiproliferative ActivityACS Medicinal Chemistry Letters, 2010
- Suitability of GRIND-Based Principal Properties for the Description of Molecular Similarity and Ligand-Based Virtual ScreeningJournal of Chemical Information and Modeling, 2009
- The Design, Synthesis, and Evaluation of Coumarin Ring Derivatives of the Novobiocin Scaffold that Exhibit Antiproliferative ActivityThe Journal of Organic Chemistry, 2008
- Novobiocin: Redesigning a DNA Gyrase Inhibitor for Selective Inhibition of Hsp90Journal of the American Chemical Society, 2006
- Hsp90 Inhibitors Identified from a Library of Novobiocin AnaloguesJournal of the American Chemical Society, 2005
- A computational procedure for determining energetically favorable binding sites on biologically important macromoleculesJournal of Medicinal Chemistry, 1985